On Tuesday, Larimar Therapeutics Inc (NASDAQ: LRMR) was -8.41% drop from the session before settling in for the closing price of $3.45. A 52-week range for LRMR has been $1.61 – $11.20.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 50.78% over the last five years. When this article was written, the company’s average yearly earnings per share was at -45.50%. With a float of $36.46 million, this company’s outstanding shares have now reached $64.03 million.
The firm has a total of 65 workers. Let’s measure their productivity. In terms of profitability, gross margin is 33.2%, operating margin of -43711.2%, and the pretax margin is -39514.94%.
Larimar Therapeutics Inc (LRMR) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Larimar Therapeutics Inc stocks. The insider ownership of Larimar Therapeutics Inc is 43.06%, while institutional ownership is 62.24%.
Larimar Therapeutics Inc (LRMR) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -45.50% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -7.80% during the next five years compared to 50.78% growth over the previous five years of trading.
Larimar Therapeutics Inc (NASDAQ: LRMR) Trading Performance Indicators
You can see what Larimar Therapeutics Inc (LRMR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.49, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -1.92 in one year’s time.
Technical Analysis of Larimar Therapeutics Inc (LRMR)
Analysing the last 5-days average volume posted by the [Larimar Therapeutics Inc, LRMR], we can find that recorded value of 0.77 million was lower than the volume posted last year of 0.97 million. As of the previous 9 days, the stock’s Stochastic %D was 62.67%.
During the past 100 days, Larimar Therapeutics Inc’s (LRMR) raw stochastic average was set at 74.88%, which indicates a significant increase from 40.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.27 in the past 14 days, which was higher than the 0.24 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.60, while its 200-day Moving Average is $4.07. Now, the first resistance to watch is $3.44. This is followed by the second major resistance level at $3.72. The third major resistance level sits at $3.88. If the price goes on to break the first support level at $2.99, it is likely to go to the next support level at $2.83. Now, if the price goes above the second support level, the third support stands at $2.55.
Larimar Therapeutics Inc (NASDAQ: LRMR) Key Stats
There are 64,028K outstanding shares of the company, which has a market capitalization of 202.33 million. As of now, sales total 0 K while income totals -80,600 K. Its latest quarter income was 0 K while its last quarter net income were -29,280 K.
